Alys Pharmaceuticals (Series A)
Funding Details
Awarder
Inbox
Date Award
February 12, 2024
Vertical
Immuno-Dermatology
Funding Amount
$100,000,000
Company Info
Founders
Craig Mello, John Harris, Brian Kim, Lars French, Eric Deutsch, Mark Prausnitz
Market
Pharmaceuticals
Location
Boston, MA, USA
Company Description

Alys Pharmaceuticals is a biopharmaceutical company focused on developing immuno-dermatology treatments.